Viridian Therapeutics, Inc.

VRDN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Jul 17, 2023 8-K
8-K Jul 10, 2023 8-K
4 Jun 20, 2023 FORM 4 SUBMISSION
4 Jun 16, 2023 4
4 Jun 16, 2023 4
4 Jun 16, 2023 4
4 Jun 16, 2023 4
8-K Jun 16, 2023 8-K
SC 13D/A Jun 14, 2023 SC 13D/A
4 Jun 6, 2023 FORM 4 SUBMISSION
144 Jun 2, 2023
SC 13G May 11, 2023 SC 13G
10-Q May 10, 2023 10-Q
8-K May 9, 2023 8-K
ARS Apr 28, 2023 ARS
DEFA14A Apr 28, 2023 DEFA14A
DEF 14A Apr 28, 2023 DEF 14A
4 Apr 12, 2023 4
8-K Apr 12, 2023 8-K
4 Mar 13, 2023 4
S-8 Mar 10, 2023 S-8
4 Mar 10, 2023 FORM 4 SUBMISSION
8-K Mar 10, 2023 8-K
10-K Mar 9, 2023 10-K
8-K Mar 8, 2023 8-K
← Newer Page 9 of 33 · 815 filings Older →